Streetbeat News

Stock Prices

PRVA

Privia Health Gr (PRVA) reported Q4 2023 adjusted EPS of $0.15, surpassing the $0.04 estimate, but its sales of $440.83M fell short of the $730.89M estimate, marking a 20.97% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:05 am

LOW

Lowe's Companies has provided its FY24 outlook, projecting revenues between $84B and $85B, which is below the $85.61B estimate. EPS is expected to be between $12.00 and $12.30, also below the $12.95 estimate. The company anticipates a -2 to -3% decline in comparable sales from the previous year, with an operating margin of 12.6% to 12.7%, interest expenses of about $1.4B, an effective tax rate of 25%, and capital expenditures of around $2B.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:04 am

BMO

Bank of Montreal (BMO) reported Q1 adjusted EPS of $1.88, missing the $2.25 estimate, and sales of $5.64B, below the $6.18B estimate. This represents a 21.57% decrease in EPS and a 17.02% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:04 am

ESPR

Esperion Therapeutics (NASDAQ:ESPR) reported Q4 earnings with a loss of $(0.50) per share, missing the $(0.48) estimate, but sales of $32.25M exceeded the $28.70M estimate, marking a 71.38% increase from last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:03 am

SLCA

US Silica Holdings (NYSE:SLCA) reported Q4 adjusted EPS of $0.28, surpassing the $0.25 estimate, but its sales of $336.00M fell short of the $343.72M estimate. This represents a 34.88% decrease in earnings and an 18.63% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

HSIC

Henry Schein (NASDAQ:HSIC) reported Q4 adjusted EPS of $0.66, missing the $0.70 estimate, and sales of $3.02B, missing the $3.04B estimate. This represents a 51.11% decrease in earnings and a 10.50% decrease in sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

LOW

Lowe's Companies reported a 6.2% decrease in Q4 comparable sales, attributed to a slowdown in DIY demand and unfavorable January winter weather.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:02 am

CLVT

Clarivate (NYSE:CLVT) reported Q4 2023 adjusted EPS of $0.23, surpassing the $0.21 estimate, with sales of $683.70M also beating the $679.68M estimate, marking a 1.24% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:01 am

LOW

Lowe's Companies (NYSE:LOW) reported Q4 earnings of $1.58 per share, missing the $1.68 estimate, and sales of $18.60B, beating the $18.45B estimate. Earnings decreased by 30.7% and sales by 17.13% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 11:01 am

ARQT

Arcutis Biotherapeutics (NASDAQ:ARQT) reported Q4 2023 earnings with a GAAP EPS of $(0.72), surpassing the $(0.76) estimate. Sales reached $13.53M, exceeding the $11.34M forecast, marking a 356.81% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 10:55 am